RecallDepth
Class II Ongoing

Metformin Hydrochloride Extended-Release Tablets USP 750 mg, 30 Tablets bottle, Rx Only, Time-Cap Labs, Inc., Repackaged By: Northwind Pharmaceuticals North Blenheim NY 12131 NDC 70934-334-30

This recall is currently active, issued November 11, 2020. It was issued by Denton Pharma, Inc..

Company
Denton Pharma, Inc.
Recall Initiated
October 8, 2020
Posted
November 11, 2020
Recall Number
D-0056-2021
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
North Blenheim, NY, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)

Distribution

Indiana - Nationwide.

Lot / Code Info

N107411901, N107411903, N107411904, N107411905, N107411906, exp 11/30/2020; N107411907, N107412001, exp 4/30/2021; N107412002, N107412004, exp 11/30/2021; N107412003, exp 7/31/2021

More recalls by Denton Pharma, Inc.

View all recalls by this company →

Other recent Class II Drug recalls